• Pharma giants like Novartis, Pfizer, and Sanofi are getting serious about a cutting edge therapy that changes human genes

    2 monthes ago - By Business Insider

    Pharma is getting serious about gene therapy, one-time treatments that modify genes to potentially cure serious diseases.
    Novartis is the first big pharma company to make a major bet on gene therapy, acquiring AveXis for $8.7 billion in April.
    Investment in the gene therapy space could change the way certain diseases are treated, although they come with high price tags.
    One-time drugs that can cure previously untreatable diseases by modifying human genes are starting to gain traction in the US.
    These cutting-edge treatments, known as gene therapies, work by inserting new genetic code into...
    Read more ...

     

  • Pharma giants like Novartis, Pfizer, and Sanofi are getting serious about a cutting edge therapy that changes human genes

    Pharma giants like Novartis, Pfizer, and Sanofi are getting serious about a cutting edge therapy that changes human genes

    2 monthes ago - By Business Insider

    Pharma is getting serious about gene therapy, one-time treatments that modify genes to potentially cure serious diseases.
    Novartis is the first big pharma company to make a major bet on gene therapy, acquiring AveXis for $8.7 billion in April.
    Investment in the gene therapy space could change the way certain diseases are treated, although they come with high price tags.
    One-time drugs that can cure previously untreatable diseases by modifying human genes are starting to gain traction in the US.
    These cutting-edge treatments, known as gene therapies, work by inserting new genetic code into...
    Read more ...